Flatter Tacrolimus Pharmacokinetic Profiles in Pediatric Kidney Transplant Recipients Receiving Liquid Formulations: A Quality Improvement Study
Pediatric Transplantation · 2026-05 · 30 (5)
DOI: 10.1111/petr.70326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 04.05.2026. Verfasst von Sarah Lafond und 5 weiteren Autor:innen. Beteiligte Einrichtung: London Health Sciences Centre, Children's Hospital, London, Ontario, Canada. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Immunosuppressive Agents. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Compounded tacrolimus suspensions are frequently used in pediatric kidney transplant recipients who cannot reliably swallow capsules or who receive medication via a gastrostomy tube. Clinicians at our center observed unusually flat mini‐pharmacokinetic (mini‐PK) profiles in patients receiving liquid tacrolimus.
Methods
We retrospectively analyzed 13 tacrolimus mini‐PK profiles (C0, C1, C2, C4) from 7 pediatric kidney transplant recipients receiving compounded liquid tacrolimus, measured by LC–MS/MS in routine clinical care. As a contemporaneous comparator measured by the same assay, we assembled mini‐PK profiles from pediatric recipients receiving capsule tacrolimus at our center (December 2024 onward). A historical capsule cohort from Berlin measured with Abbott Tacrolimus II immunoassay was used only as external context.
Results
Contemporary LC–MS/MS capsule profiles showed the expected early post‐dose rise, whereas liquid profiles remained comparatively flat across the 0–4 h window. In the historical capsule cohort, higher trough concentrations were associated with lower C max /C min ratios, consistent with a trough‐dependent change in apparent PK shape.
Conclusions
In this Quality Improvement (QI) analysis, pediatric patients receiving compounded liquid tacrolimus demonstrated flatter mini‐PK profiles than contemporaneous capsule recipients when evaluated within the same analytical platform. These findings support closer attention to PK shape (not trough alone) in clinically complex children requiring liquid formulations and motivate prospective studies that control for gastrointestinal comorbidity, co‐medications, and administration route.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- London Health Sciences Centre, Children's Hospital, London, Ontario, Canada.
- Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Hospital Infantil de México Federico Gómez, Unidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo, Mexico City, Mexico.
- Department of Pharmacy, London Health Sciences Centre, London, Ontario, Canada.
- Undergraduate Health Sciences Program, Western University, London, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, Western University and LHSC, London, Ontario, Canada.
ORCID-Profile: Mara Medeiros-Domingo, Guido Filler
Zitieren
APA
Lafond, S., Medeiros-Domingo, M., Henderson, S., Fayaz, D., Nichols, M., & Filler, G. (2026). Flatter Tacrolimus Pharmacokinetic Profiles in Pediatric Kidney Transplant Recipients Receiving Liquid Formulations: A Quality Improvement Study. Pediatric Transplantation, 30(5). https://doi.org/10.1111/petr.70326
Vancouver
Lafond S, Medeiros-Domingo M, Henderson S, Fayaz D, Nichols M, Filler G. Flatter Tacrolimus Pharmacokinetic Profiles in Pediatric Kidney Transplant Recipients Receiving Liquid Formulations: A Quality Improvement Study. Pediatric Transplantation. 2026;30(5). doi:10.1111/petr.70326
BibTeX
@article{Lafond2026,
author = {Lafond, Sarah and Medeiros-Domingo, Mara and Henderson, Sara and Fayaz, Dua and Nichols, Matthew and Filler, Guido},
title = {Flatter Tacrolimus Pharmacokinetic Profiles in Pediatric Kidney Transplant Recipients Receiving Liquid Formulations: A Quality Improvement Study},
journal = {Pediatric Transplantation},
year = {2026},
volume = {30},
number = {5},
doi = {10.1111/petr.70326}
}
EUVIMED